Intravenous iron isomaltoside 1000 administered by high single-dose infusions or standard medical care for the treatment of fatigue in women after postpartum haemorrhage: study protocol for a randomised controlled trial

MLA

Astrid Norgaard, et al. “Intravenous Iron Isomaltoside 1000 Administered by High Single-Dose Infusions or Standard Medical Care for the Treatment of Fatigue in Women after Postpartum Haemorrhage: Study Protocol for a Randomised Controlled Trial.” Trials, vol. 16, no. 1. EBSCOhost, https://doi.org/10.1186/1745-6215-16-5. Accessed 22 Jan. 2025.

APA

Astrid Norgaard, Jens Langhoff-Roos, Lars Lykke Thomsen, & Charlotte Holm. (n.d.). Intravenous iron isomaltoside 1000 administered by high single-dose infusions or standard medical care for the treatment of fatigue in women after postpartum haemorrhage: study protocol for a randomised controlled trial. Trials, 16(1). https://doi.org/10.1186/1745-6215-16-5

Chicago

Astrid Norgaard, Jens Langhoff-Roos, Lars Lykke Thomsen, and Charlotte Holm. 2025. “Intravenous Iron Isomaltoside 1000 Administered by High Single-Dose Infusions or Standard Medical Care for the Treatment of Fatigue in Women after Postpartum Haemorrhage: Study Protocol for a Randomised Controlled Trial.” Trials 16 (1). Accessed January 22. doi:10.1186/1745-6215-16-5.